New Stock News | HealthyWay Inc.'s Hong Kong IPO prospectus invalidated: Operating one of the largest digital health and medical service platforms in China

According to the information obtained from the Wise Finance APP, HealthyWay Inc. submitted its Hong Kong stock prospectus on December 29, 2023, which will expire after 6 months on June 29, with Haitong International as its exclusive sponsor at the time of submission. As disclosed in the prospectus, HealthyWay is committed to becoming the most valuable service platform in the Chinese health and wellness industry. Since 2001, it has been providing digital health medical services to individual users, and since 2015, it has been providing enterprise solutions and digital marketing solutions to businesses and institutions. According to Frost & Sullivan data, as of December 31, 2022, based on the number of registered individual users on the platform, the company operates one of China's largest digital health medical service platforms. The company's digital health medical services enable it to establish strong and extensive connections between the supply and demand sides of the Chinese digital health and wellness market. For individual users, the company mainly provides digital health medical services to help them manage their health and wellness more easily. For enterprises and institutions, the company mainly provides enterprise solutions and digital marketing solutions to improve their operational efficiency. In addition, the company also introduces doctors to play a key role on the platform. Users can access the HealthyWay platform through multiple channels such as the HealthyWay mobile application, medical care network, the company's WeChat official account, and WeChat mini programs. Financially, as of the fiscal years 2020, 2021, 2022, and the six months ended June 30, 2022, and 2023, the company's revenues were approximately RMB 187 million, 431 million, 569 million, 286 million, and 534 million respectively. During the same period, the company's losses increased year by year, with annual losses of approximately RMB 65.328 million, 155 million, 256 million, 80.012 million, and 105 million respectively